Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
11.20
+1.16 (11.55%)
At close: Aug 13, 2025, 4:00 PM
11.20
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:10 PM EDT

Aardvark Therapeutics Statistics

Total Valuation

AARD has a market cap or net worth of $242.99 million. The enterprise value is $101.82 million.

Market Cap 242.99M
Enterprise Value 101.82M

Important Dates

The next confirmed earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

AARD has 21.70 million shares outstanding. The number of shares has increased by 170.95% in one year.

Current Share Class 21.70M
Shares Outstanding 21.70M
Shares Change (YoY) +170.95%
Shares Change (QoQ) +64.98%
Owned by Insiders (%) 14.49%
Owned by Institutions (%) 17.94%
Float 11.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.61
P/TBV Ratio 1.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.04, with a Debt / Equity ratio of 0.00.

Current Ratio 14.04
Quick Ratio 13.76
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -33.09% and return on invested capital (ROIC) is -22.98%.

Return on Equity (ROE) -33.09%
Return on Assets (ROA) -21.76%
Return on Invested Capital (ROIC) -22.98%
Return on Capital Employed (ROCE) -29.79%
Revenue Per Employee n/a
Profits Per Employee -$1.67M
Employee Count 22
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 12.48
200-Day Moving Average n/a
Relative Strength Index (RSI) 43.19
Average Volume (20 Days) 45,447

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -40.86M
Pretax Income -13.85M
Net Income -36.64M
EBITDA -40.84M
EBIT -40.86M
Earnings Per Share (EPS) -$3.41
Full Income Statement

Balance Sheet

The company has $141.82 million in cash and $645,000 in debt, giving a net cash position of $141.18 million or $6.51 per share.

Cash & Cash Equivalents 141.82M
Total Debt 645,000
Net Cash 141.18M
Net Cash Per Share $6.51
Equity (Book Value) 136.93M
Book Value Per Share 6.31
Working Capital 134.46M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -170.95%
Shareholder Yield -170.95%
Earnings Yield -15.08%
FCF Yield n/a

Analyst Forecast

The average price target for AARD is $33.00, which is 194.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.00
Price Target Difference 194.64%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a